ADVERTISEMENT
Search

 

Press Releases

 

16

May

2024

APhA announces results of 2024 Board elections

WASHINGTON, DC—Today the American Pharmacists Association (APhA) announced the election of Magaly Rodriguez de Bittner, PharmD, FNAP, FAPhA, of Pasadena, MD, as 2025–2026 APhA president-elect. Rodrigeuz de Bittner will succeed Randy P. McDonough, BS, PharmD, MS, BCGP, BCPS, RPh, of Iowa City, IA, in the office of APhA president on March 30, 2026, at the conclusion of the 2026 APhA Annual Meeting & Exposition in Los Angeles, CA.

Comments (0)
Number of views (474)
Article rating: No rating

4

Apr

2024

APhA and CDC select Community of Practice Teams to advance health equity and prevent heart disease and stroke

WASHINGTON, DC—The American Pharmacists Association (APhA) and CDC are proud to announce the selected Community of Practice (CoP) Teams as part of the Advancing Health Equity with Pharmacy-Based Strategies, Pharmacists Patient Care Services and Support Services project to advance health equity and prevent heart disease and stroke in the United States.

Comments (0)
Number of views (1981)
Article rating: No rating

18

Mar

2024

APhA and NASPA release eighth PWWR report and learnings

Washington, DC—Today the American Pharmacists Association (APhA) and the National Alliance of State Pharmacy Associations (NASPA) released the eighth installment of the Pharmacy Workplace and Well-being Reporting (PWWR) trends and learnings report series.1

Comments (0)
Number of views (1046)
Article rating: No rating

10

Jan

2024

APhA Announces Nahata as the 2024 Remington Honor Medal Recipient

WASHINGTON - Today, the American Pharmacists Association (APhA) began announcing the selection of the 2024 APhA Awards and Honors Program recipients. The APhA Awards and Honors Program is the most comprehensive recognition program in the profession of pharmacy.

Comments (0)
Number of views (3660)
Article rating: No rating

5

Jan

2024

FDA’s decision on Florida’s importation program jeopardizes patient safety

WASHINGTON, DC — The American Pharmacists Association (APhA) is dismayed that FDA gave the green light to Florida to import prescription drugs from Canada, jeopardizing patient safety and compromising our nations’ drug supply.

Comments (0)
Number of views (3831)
Article rating: No rating
RSS
123456
ADVERTISEMENT